KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Receivables - Other (2016 - 2026)

Eli Lilly filings provide 15 years of Receivables - Other readings, the most recent being $2.7 billion for Q1 2026.

  • On a quarterly basis, Receivables - Other rose 39.73% to $2.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.7 billion, a 39.73% increase, with the full-year FY2025 number at $2.4 billion, up 5.51% from a year prior.
  • Receivables - Other hit $2.7 billion in Q1 2026 for Eli Lilly, up from $2.4 billion in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $3.3 billion in Q3 2025 to a low of $1.3 billion in Q2 2022.
  • Median Receivables - Other over the past 5 years was $2.1 billion (2024), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Receivables - Other: decreased 20.02% in 2024 and later soared 90.67% in 2025.
  • Eli Lilly's Receivables - Other stood at $1.7 billion in 2022, then surged by 35.05% to $2.2 billion in 2023, then increased by 1.08% to $2.3 billion in 2024, then rose by 5.51% to $2.4 billion in 2025, then rose by 14.74% to $2.7 billion in 2026.
  • The last three reported values for Receivables - Other were $2.7 billion (Q1 2026), $2.4 billion (Q4 2025), and $3.3 billion (Q3 2025) per Business Quant data.